Management of Multiple Myeloma: A Review for General Practitioners in Oncology.

Autor: Monteith, Bethany E.¹ (AUTHOR) bethany.monteith@kingstonhsc.ca, Sandhu, Irwindeep² (AUTHOR) irwindeep.sandhu@ualberta.ca, Lee, Ann S.³ (AUTHOR) ann.lee@ualberta.ca

Publikováno v: Current Oncology. May2023, Vol. 30 Issue 5, p4382-4401. 20p. 2 Diagrams, 4 Charts.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A descriptive cost‐analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high‐dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.

Autor: Monteith, Bethany E.^1,2 (AUTHOR) Bethany.Monteith@queensu.ca, Venner, Christopher P.³ (AUTHOR), Cheung, Matthew C.⁴ (AUTHOR), Pater, Joe¹ (AUTHOR), Shepherd, Lois¹ (AUTHOR), Richardson, Harriet¹ (AUTHOR), Reece, Donna⁵ (AUTHOR), Gul, Engin⁶ (AUTHOR), Lalancette, Marc⁷ (AUTHOR), Castonguay, Vincent⁷ (AUTHOR), Kukreti, Vishal⁵ (AUTHOR), Tiedemann, Rodger⁵ (AUTHOR), Phua, Chai⁸ (AUTHOR), Bhella, Sita² (AUTHOR), Dudebout, Jill² (AUTHOR), Sherry, Max¹ (AUTHOR), Yen, Hope¹ (AUTHOR), Chen, Bingshu E.¹ (AUTHOR), Hay, Annette E.^1,2 (AUTHOR)

Publikováno v: European Journal of Haematology. Sep2021, Vol. 107 Issue 3, p333-342. 10p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Unusual Carfilzomib Toxicity: Three Cases of Drug-induced Thrombotic Microangiopathy (TMA) after Treatment with High-dose weekly Carfilzomib, Cyclophosphamide, and Dexamethasone (wCCD)

Autor: Monteith, Bethany, Venner, Chritopher, Reece, Donna, Kew, Andrea, Lalancette, Marc, Garland, Jocelyn, Shepherd, Lois, McDonald, Gail, Gul, Engin, Pater, Joe, Hay, Annette

Publikováno v: In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e272-e273